THBS1 and urinary bladder cancer: Our data and previous reports show direct effects of both SAHA and valproate on bladder cancer cells in vitro and suggest that anti-angiogenic properties of this class of drugs could be mediated through induction of the anti-angiogenic protein TSP1.